Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$949.64M
Total Bought
$97.76M
Total Sold
$123.07M
Net Transaction
-$25.32M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
Dyne Therapeutics, Inc.(DYN)8,020,1368,020,1360227,692283,03129.80%+55,339
Third Harmonic Bio, Inc.10,907,85910,907,8590102,970141,80214.93%+38,832
Tectonic Therapeutics, Inc.0378,447+378,44706,2330.66%+6,233
Vigil Neuroscience, Inc.5,836,8745,836,874019,90423,3472.46%+3,444
Q32 Bio, Inc.2,092,1062,092,106035,64937,5533.95%+1,904
Replimune Group, Inc.(REPL)2,098,3002,098,300017,14318,8851.99%+1,742
Ikena Oncology, Inc.5,018,1785,018,17807,1268,2800.87%+1,154
Spero Therapeutics, Inc.607,613535,336-72,2771,0456960.07%-349
Xilio Therapeutics, Inc.992,9120-992,9121,0720-1,072
Dianthus Therapeutics, Inc.(DNTH)186,979136,979-50,0005,6093,5450.37%-2,064
AvroBio, Inc.4,541,3810-4,541,3815,8130-5,813
Generation Bio, Co.8,279,4848,279,484033,69823,3482.46%-10,349
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,2570106,22888,6099.33%-17,619
Disc Medicine, Inc.(IRON)2,287,2332,509,456+222,223142,403113,10111.91%-29,302
Kymera Therapeutics, Inc.(KYMR)5,377,3625,350,422-26,940216,170159,71016.82%-56,460
Aerovate Therapeutics, Inc.2,039,2491,799,232-240,01760,3012,9870.31%-57,314
Korro Bio, Inc.1,119,2921,137,149+17,857100,73638,5154.06%-62,221
Page 1 of 1